Get the Stockscreener App
4.50
7.79%
-0.38
Pre-market:
4.51
0.010
+0.22%
Avalon Globocare Corp stock is traded at $4.50, with a volume of 21,039.
It is down -7.79% in the last 24 hours and up +20.97% over the past month.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.
See More
Previous Close:
$4.88
Open:
$4.74
24h Volume:
21,039
Relative Volume:
0.03
Market Cap:
$4.92M
Revenue:
$1.31M
Net Income/Loss:
$-14.73M
P/E Ratio:
-0.2252
EPS:
-19.98
Net Cash Flow:
$-4.69M
1W Performance:
-58.72%
1M Performance:
+20.97%
6M Performance:
+20.00%
1Y Performance:
-20.42%
1-Day Range:
$4.36
$4.74
1-Week Range:
$4.36
$11.51
52-Week Range:
$2.11
$21.60
Avalon Globocare Corp Stock (ALBT) Company Profile
Name
Avalon Globocare Corp
Sector
Industry
Phone
732-780-4400
Address
4400 ROUTE 9, FREEHOLD
Compare ALBT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALBT
Avalon Globocare Corp
|
4.50 | 4.92M | 1.31M | -14.73M | -4.69M | -19.98 |
|
CBRE
Cbre Group Inc
|
121.79 | 36.54B | 35.77B | 968.00M | 1.40B | 3.14 |
|
CSGP
Costar Group Inc
|
75.44 | 31.82B | 2.74B | 138.70M | -245.30M | 0.35 |
|
BEKE
Ke Holdings Inc Adr
|
22.44 | 27.09B | 10.78B | 579.98M | 881.47M | 0.493 |
|
JLL
Jones Lang Lasalle Inc
|
239.83 | 11.37B | 22.50B | 478.00M | 411.90M | 9.89 |
|
FSV
Firstservice Corp
|
159.66 | 7.26B | 4.93B | 108.16M | 203.45M | 2.40 |
Avalon Globocare Corp Stock (ALBT) Latest News
Short Interest in Avalon GloboCare Corp. (NASDAQ:ALBT) Rises By 358.6% - Defense World
ALBT Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of Avalon GloboCare Corp. is Fair to - EIN News
ALBT Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of Avalon GloboCare Corp. is Fair to Shareholders - The Bakersfield Californian
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Avalon GloboCare Corp.ALBT - PR Newswire
Shareholder Alert: The Ademi Firm investigates whether Avalon GloboCare Corp. is obtaining a Fair Price for its Public Shareholders - Business Wire
Avalon Globocare and Yoov to merge -March 10, 2025 at 10:45 am EDT - Marketscreener.com
Avalon GloboCare and YOOV To Merge - citybiz
Avalon GloboCare Announces Merger with YOOV Group - TipRanks
Avalon announces merger with AI firm YOOV, sees revenue surge - Investing.com India
Avalon GloboCare, YOOV Group Holding enter merger agreement - TipRanks
Avalon announces merger with AI firm YOOV, sees revenue surge By Investing.com - Investing.com Australia
Avalon GloboCare and YOOV, a Leading Business AI Automation Solutions Provider, Enter into Merger Agreement - GlobeNewswire
(ALBT) Trading Signals - Stock Traders Daily
Short Interest in Avalon GloboCare Corp. (NASDAQ:ALBT) Rises By 37.5% - Defense World
Avalon GloboCare finalizes equity interest redemption deal By Investing.com - Investing.com South Africa
Avalon GloboCare finalizes equity interest redemption deal - Investing.com India
Avalon GloboCare (NASDAQ: ALBT) Receives Notice of Allowance for Innovative CAR-T and CAR-NK Cell Technology in ChinaFREEHOLD, N.J., February 18, 2025 – Avalon GloboCare Corp. (NASDAQ: ALBT), a leading developer of precision diagnostics a - Defense World
Avalon GloboCare Receives Notice of Allowance for Groundbreaking CAR-T and CAR-NK Cell Technology in China - GlobeNewswire
Avalon GloboCare Receives Notice of Allowance for Chimeric Antigen Receptor Cell Technology in China - Marketscreener.com
Avalon GloboCare Secures Patent for CAR-T Technology - TipRanks
Avalon GloboCare secures patent in China for CAR therapy tech By Investing.com - Investing.com South Africa
Avalon GloboCare secures patent in China for CAR therapy tech - Investing.com
Revolutionary Cancer Treatment Patent: Avalon's Dual-Target CAR-T Therapy Gets China's Green Light - StockTitan
Avalon GloboCare Corp. (NASDAQ:ALBT) Short Interest Update - Defense World
Head to Head Analysis: Sangamo Therapeutics (NASDAQ:SGMO) versus Avalon GloboCare (NASDAQ:ALBT) - Defense World
Avalon GloboCare announces preferred stock exchange and amendment By Investing.com - Investing.com Australia
Avalon GloboCare announces preferred stock exchange and amendment - Investing.com India
Avalon GloboCare Appoints Dr. Charles Cavo to its Scientific and Clinical Advisory Board - Marketscreener.com
Avalon GloboCare Corp. (NASDAQ:ALBT) Sees Significant Increase in Short Interest - Defense World
Avalon GloboCare Enters into Securities Purchase Agreement with InvestorOn December 19, 2024, Avalon GloboCare Corp. (NASDAQ: ALBT) announced that it had entered into a securities purchase agreement with an accredited investor, York Sun Investme - Defense World
Avalon GloboCare announces $7M preferred stock sale By Investing.com - Investing.com Nigeria
Avalon GloboCare announces $7M preferred stock sale - Investing.com India
Avalon GloboCare (NASDAQ:ALBT) vs. Krystal Biotech (NASDAQ:KRYS) Head-To-Head Analysis - Defense World
3 Penny Stocks to Watch Now, 12/10/24 - TipRanks
Why Interpublic Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket - Benzinga
Avalon GloboCare Regains Nasdaq Compliance - Investing.com
Avalon GloboCare Achieves Nasdaq Compliance with Strong Governance - TipRanks
Avalon GloboCare Regains Compliance with Nasdaq Continued Listing Requirements - GlobeNewswire
Avalon GloboCare Regains Nasdaq Compliance, Reaffirms Growth Strategy | ALBT Stock News - StockTitan
Avalon launches ‘BrAce for Impact’ affiliate marketing program - TipRanks
Avalon GloboCare Launches “BrAce for Impact" Affiliate Marketing Program for the KetoAir Breathalyzer Device - GlobeNewswire
Avalon GloboCare Launches AI-Powered KetoAir™ Affiliate Program for Ketosis Monitoring | ALBT Stock News - StockTitan
Critical Review: Innate Pharma (NASDAQ:IPHA) vs. Avalon GloboCare (NASDAQ:ALBT) - Defense World
Avalon GloboCare Third Quarter 2024 Earnings: US$1.82 loss per share (vs US$2.06 loss in 3Q 2023) - Yahoo Finance
Avalon GloboCare Corp. (ALBT) Quarterly 10-Q Report - Quartz
U.S. Stock market: Zoomcar Holdings (+192.21%), Avalon GloboCare (+56.73%), and Vimeo (+40.85%) experience significant gains during mid day trading - Business Upturn
U.S. Stock market: Zoomcar Holdings up 87.10%, Avalon GloboCare jumps 57.14%, Vimeo rises 44.07% among top gainers - Business Upturn
Avalon Globocare Corp Stock (ALBT) Financials Data
Revenue
Net Income
Cash Flow
EPS
6.77%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):